Psychological and psychosocial interventions for cannabis cessation in adults: A systematic review short report

Health Technology Assessment

Volumn 19, Issue 56, 2015, Pages 1-129

  Cooper, Katy ^a   Chatters, Robin ^a   Kaltenthaler, Eva ^a   Wong, Ruth ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

ARTICLE; BIPOLAR DISORDER; CANNABIS ADDICTION; CANNABIS USE; CASE MANAGEMENT; CLINICAL EFFECTIVENESS; COGNITIVE REMEDIATION THERAPY; COGNITIVE THERAPY; CONTINGENCY MANAGEMENT; FOLLOW UP; GROUP THERAPY; HEALTH PROMOTION; HUMAN; INTERMETHOD COMPARISON; MAJOR DEPRESSION; MOTIVATIONAL INTERVIEWING; PATIENT COMPLIANCE; PROGRAM COST EFFECTIVENESS; PSYCHOSIS; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; SOCIAL SUPPORT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; WITHDRAWAL SYNDROME; GROUP PROCESS; MARIJUANA ABUSE; MENTAL DISORDERS; PROCEDURES;

COGNITIVE THERAPY; GROUP PROCESSES; HUMANS; MARIJUANA ABUSE; MENTAL DISORDERS; MOTIVATIONAL INTERVIEWING; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84938599982     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta19560     Document Type: Article

References (97)

1. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009;374:1383–91. http://dx.doi.org/10.1016/S0140-6736(09)61037-0
2. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems. Geneva: World Health Organization; 2000.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text Revision (DSM-IV-TR). American Psychiatric Press Inc.; 2000.
4. Danovitch I, Gorelick DA. State of the art treatments for cannabis dependence. Psychiatr Clin North Am 2012;35:309–26. http://dx.doi.org/10.1016/j.psc.2012.03.003
5. Stinson FS, Ruan WJ, Pickering R, Grant BF. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol Med 2006;36:1447–60. http://dx.doi.org/10.1017/S0033291706008361
6. Hunt GE, Siegfried N, Morley K, Sitharthan T, Cleary M, Hunt GE, et al. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Syst Rev 2013;10:CD001088. http://dx.doi.org/10.1002/14651858.cd001088.pub3
7. United Nations Office on Drugs and Crime. World Drug Report 2013. New York, NY: United Nations; 2013.
8. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Prevalence of Daily Cannabis Use in the European Union and Norway. Lisbon: EMCDDA; 2012.
9. Grant BF, Pickering R. The relationship between cannabis use and DSM-IV cannabis abuse and dependence: Results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse 1998;10:255–64. http://dx.doi.org/10.1016/S0899-3289(99)00006-1
10. Swift W, Hall W, Teesson M. Cannabis use and dependence among Australian adults: Results from the National Survey of Mental Health and Wellbeing. Addiction 2001;96:737–48. http://dx.doi.org/10.1046/j.1360-0443.2001.9657379.x
11. Swift W, Copeland J, Hall W. Choosing a diagnostic cut-off for cannabis dependence. Addiction 1998;93:1681–92. http://dx.doi.org/10.1046/j.1360-0443.1998.931116816.x
12. Denis C, Lavie E, Fatseas M, Auriacombe M, Denis C, Lavie E, et al. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cochrane Database of Syst Rev 2006;3:CD005336.
13. Winstock AR, Ford C, Witton J. Assessment and management of cannabis use disorders in primary care. BMJ 2010; 340:800–4. http://dx.doi.org/10.1136/bmj.c1571
14. Budney AJ, Novy PL, Hughes JR. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction 1999;94:1311–22. http://dx.doi.org/10.1046/j.1360-0443.1999.94913114.x
15. van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M. Facilitators and barriers in treatment seeking for cannabis dependence. Drug Alcohol Depend 2013;133:776–80. http://dx.doi.org/10.1016/j.drugalcdep.2013.08.011
16. Brorson HH, Ajo AE, Rand-Hendriksen K, Duckert F. Drop-out from addiction treatment: a systematic review of risk factors. Clin Psychol Rev 2013;33:1010–24. http://dx.doi.org/10.1016/j.cpr.2013.07.007
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. (DSM-5®). American Psychiatric Press Inc.; 2013.
18. American Psychiatric Association. Substance-Related and Addictive Disorders. American Psychiatric Press Inc.; 2013.
19. NICE. NICE Clinical Guideline 51: Drug Misuse: Psychosocial Interventions. London, UK: NICE; 2007.
20. Department of Health (England). Drug Misuse and Dependence: UK Guidelines on Clinical Management. Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive; 2007.
21. European Monitoring Centre for Drugs and Drug Addiction. Best Practice Portal: Treatment Options for Cannabis Users. 2014. URL: www.emcdda.europa.eu/best-practice/treatment/cannabis-users (accessed 6 February 2014).
22. McRae AL, Budney AJ, Brady KT, McRae AL, Budney AJ, Brady KT. Treatment of marijuana dependence: A review of the literature. J Subst Abuse Treat 2003;24:369–766. http://dx.doi.org/10.1016/S0740-5472(03)00041-2
23. Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW, et al. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008;165:179–87. http://dx.doi.org/10.1176/appi.ajp.2007.06111851
24. Tait RJ, Spijkerman R, Riper H. Internet and computer based interventions for cannabis use: A meta-analysis. Drug Alcohol Depend 2013;133:295–304. http://dx.doi.org/10.1016/j.drugalcdep.2013.05.012
25. Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs 2009;70:516–27. http://dx.doi.org/10.15288/jsad.2009.70.516
26. Wood SK, Eckley L, Hughes K, Hardcastle KA, Bellis MA, Schrooten J, et al. Computer-based programmes for the prevention and management of illicit recreational drug use: A systematic review. Addict Behav 2014;39:30–8. http://dx.doi.org/10.1016/j.addbeh.2013.09.010
27. Chiesa A, Serretti A. Are mindfulness-based interventions effective for substance use disorders? A systematic review of the evidence. Subst Use Misuse 2013;49:492–512. http://dx.doi.org/10.3109/10826084.2013.770027
28. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA statement. PLOS Med 2009;6:e1000097. http://dx.doi.org/10.1371/journal.pmed.1000097
29. NHS Choices. Cognitive Behavioural Therapy. 2012. URL: www.nhs.co.uk/conditions/cognitive-behavioural-therapy/Pages/Introduction.aspx(accessed 6 February 2014).
30. Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York, NY: Guilford Press; 1991.
31. Smedslund G, Berg RC, Hammerstrom KT, Steiro A, Leiknes KA, Dahl HM, et al. Motivational interviewing for substance abuse. Cochrane Database Syst Rev 2011;5:CD008063. http://dx.doi.org/10.1002/14651858.cd008063.pub2
32. Maddock CBM. Interventions for cannabis misuse. Adv Psychiatr Treat 2006;12:432–9. http://dx.doi.org/10.1192/apt.12.6.432
33. Hesse M, Vanderplasschen W, Rapp R, Broekaert E, Fridell M. Case management for persons with substance use disorders. Cochrane Database Syst Rev 2007;17:CD006265. http://dx.doi.org/10.1002/14651858.cd006265.pub2
34. McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980;168:26–33. http://dx.doi.org/10.1097/00005053-198001000-00006
35. Copeland J, Gilmour S, Gates P, Swift W. The Cannabis Problems Questionnaire: factor structure, reliability, and validity. Drug Alcohol Depend 2005;80:313–19. http://dx.doi.org/10.1016/j.drugalcdep.2005.04.009
36. Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the Conduct of Narrative Synthesis in Systematic Reviews. 2006. URL: www.lancaster.ac.uk/shm/research/nssr/research/dissemination/publications/NS_Synthesis_Guidance:v1.pdf (accessed 6 February 2014).
37. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. http://dx.doi.org/10.1136/bmj.d5928
38. Schulz KF, Grimes DA. Sample size slippages in randomised trials: Exclusions and the lost and wayward. Lancet 2002;359:781–5. http://dx.doi.org/10.1016/S0140-6736(02)07882-0
39. Babor TF, Carroll K, Christiansen K, Donaldson J, Herrell J, Kadden R, et al. Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol 2004;72:455–66. http://dx.doi.org/10.1037/0022-006X.72.3.455
40. Budney AJ, Higgins ST, Radonovich KJ, Novy PL, Budney AJ, Higgins ST, et al. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 2000;68:1051–61. http://dx.doi.org/10.1037/0022-006X.68.6.1051
41. Budney AJ, Moore BA, Rocha HL, Higgins ST. Clinical trial of abstinence-based vouchers and cognitive–behavioral therapy for cannabis dependence. J Consult Clin Psychol 2006;74:307–16. http://dx.doi.org/10.1037/0022-006X.74.2.307
42. Budney AJ, Stanger C, Costello P, Fearer S, Walker DD, Bickel WK. Computer-Assisted Delivery of Behavioral Treatment for Cannabis Use Disorders: Preliminary Results from a Controlled Trial and Implications for Dissemination. Proceedings of the 73rd Annual Scientific Meeting of the College on Problems of Drug Dependence 2011. URL: www.cpdd.org/Pages/Meetings/CPDD11AbstractBook.pdf (accessed 6 February 2014).
43. de Dios MA, Herman DS, Britton WB, Hagerty CE, Anderson BJ, Stein MD, et al. Motivational and mindfulness intervention for young adult female marijuana users. J Subst Abuse Treat 2012;42:56–64. http://dx.doi.org/10.1016/j.jsat.2011.08.001
44. Kadden RM, Litt MD, Kabela-Cormier E, Petry NM. Abstinence rates following behavioural treatments for marijuana dependence. Addict Behav 2007;32:1220–36. http://dx.doi.org/10.1016/j.addbeh.2006.08.009
45. Lee CM, Neighbors C, Kilmer JR, Larimer ME. A brief, web-based personalized feedback selective intervention for college student marijuana use: A randomized clinical trial. Psychol Addict Behav 2010;24:265–73. http://dx.doi.org/10.1037/a0018859
46. Lee CM, Kilmer JR, Neighbors C, Atkins DC, Zheng C, Walker DD, et al. Indicated prevention for college student marijuana use: A randomized controlled trial. J Consult Clin Psychol 2013;81:702–9. http://dx.doi.org/10.1037/a0033285
47. Litt MD, Kadden RM, Petry NM. Behavioral treatment for marijuana dependence: Randomized trial of contingency management and self-efficacy enhancement. Addict Behav 2013;38:1764–75. http://dx.doi.org/10.1016/j.addbeh.2012.08.011
48. Stein MD, Hagerty CE, Herman DS, Phipps MG, Anderson BJ. A brief marijuana intervention for non-treatment-seeking young adult women. J Subst Abuse Treat 2011;40:189–98. http://dx.doi.org/10.1016/j.jsat.2010.11.001
49. Stephens RS, Roffman RA, Simpson EE. Treating adult marijuana dependence: A test of the relapse prevention model. J Consult Clin Psychol 1994;62:92–9. http://dx.doi.org/10.1037/0022-006X.62.1.92
50. Stephens RS, Roffman RA, Curtin L. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol 2000;68:898–908. http://dx.doi.org/10.1037/0022-006X.68.5.898
51. Stephens RS, Roffman RA, Fearer SA, Williams C, Burke RS. The Marijuana Check-up: promoting change in ambivalent marijuana users. Addiction 2007;102:947–57. http://dx.doi.org/10.1111/j.1360-0443.2007.01821.x
52. Baker A, Bucci S, Lewin TJ, Kay-Lambkin F, Constable PM, Carr VJ, et al. Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial. Br J Psychiatry 2006;188:439–48. http://dx.doi.org/10.1192/bjp.188.5.439
53. Copeland J, Swift W, Roffman R, Stephens R. A randomized controlled trial of brief cognitive–behavioral interventions for cannabis use disorder. J Subst Abuse Treat 2001;21:55–64. http://dx.doi.org/10.1016/S0740-5472(01)00179-9
54. Edwards J, Elkins K, Hinton M, Harrigan SM, Donovan K, Athanasopoulos O, et al. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatr Scand 2006;114:109–17. http://dx.doi.org/10.1111/j.1600-0447.2006.00783.x
55. Gates PJ, Norberg MM, Copeland J, Digiusto E. Randomized controlled trial of a novel cannabis use intervention delivered by telephone. Addiction 2012;107:2149–58. http://dx.doi.org/10.1111/j.1360-0443.2012.03953.x
56. Grenyer BF, Solowij N, Peters R. Brief versus intensive psychotherapy for cannabis dependence. NIDA Research Monograph 1997;174:108.
57. Kay-Lambkin FJ, Baker AL, Lewin TJ, Carr VJ. Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: A randomized controlled trial of clinical efficacy. Addiction 2009;104:378–88. http://dx.doi.org/10.1111/j.1360-0443.2008.02444.x
58. Kay-Lambkin FJ, Baker AL, Kelly B, Lewin TJ. Clinician-assisted computerised versus therapist-delivered treatment for depressive and addictive disorders: A randomised controlled trial. Med J Aust 2011;195:S44–50.
59. Hoch E, Noack R, Henker J, Pixa A, Hofler M, Behrendt S, et al. Efficacy of a targeted cognitive–behavioral treatment program for cannabis use disorders (CANDIS). Eur Neuropsychopharmacol 2012;22:267–80. http://dx.doi.org/10.1016/j.euroneuro.2011.07.014
60. Hoch E, Buhringer G, Pixa A, Dittmer K, Henker J, Seifert A, et al. CANDIS treatment program for cannabis use disorders: Findings from a randomized multi-site translational trial. Drug Alcohol Depend 2014;134:185–93. http://dx.doi.org/10.1016/j.drugalcdep.2013.09.028
61. Tossmann HP, Jonas B, Tensil MD, Lang P, Strüber E. A controlled trial of an internet-based intervention program for cannabis users. Cyberpsychol Behav Social Network 2011;14:673–9. http://dx.doi.org/10.1089/cyber.2010.0506
62. Fernandes S, Ferigolo M, Benchaya MC, Moreira TC, Pierozan PS, Mazoni CG, et al. Brief Motivational Intervention and telemedicine: A new perspective of treatment to marijuana users. Addict Behav 2010;35:750–5. http://dx.doi.org/10.1016/j.addbeh.2010.03.001
63. Jungerman FS, Andreoni S, Laranjeira R. Short term impact of same intensity but different duration interventions for cannabis users. Drug Alcohol Depend 2007;90:120–7. http://dx.doi.org/10.1016/j.drugalcdep.2007.02.019
64. Fischer B, Dawe M, McGuire F, Shuper PA, Capler R, Bilsker D, et al. Feasibility and impact of brief interventions for frequent cannabis users in Canada. J Subst Abuse Treat 2013;44:132–8. http://dx.doi.org/10.1016/j.jsat.2012.03.006
65. Sobell LC, Sobell MB, Agrawal S. Randomized controlled trial of a cognitive-behavioral motivational intervention in a group versus individual format for substance use disorders. Psychology Addict Behav 2009;23:672–83. http://dx.doi.org/10.1037/a0016636
66. Bonsack C, Gibellini MS, Favrod J, Montagrin Y, Besson J, Bovet P, et al. Motivational intervention to reduce cannabis use in young people with psychosis: a randomized controlled trial. Psychother Psychosom 2011;80:287–97. http://dx.doi.org/10.1159/000323466
67. Gmel G, Gaume J, Bertholet N, Fluckiger J, Daeppen JB. Effectiveness of a brief integrative multiple substance use intervention among young men with and without booster sessions. J Subst Abuse Treat 2013;44:231–40. http://dx.doi.org/10.1016/j.jsat.2012.07.005
68. Hjorthoj CR, Fohlmann A, Larsen AM, Gluud C, Arendt M, Nordentoft M. Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: The CapOpus randomized trial. Psychol Med 2013;43:1499–510. http://dx.doi.org/10.1017/S0033291712002255
69. Madigan K, Brennan D, Lawlor E, Turner N, Kinsella A, O’Connor JJ, et al. A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophr Res 2013;143:138–42.http://dx.doi.org/10.1016/j.schres.2012.10.018
70. Rooke S, Copeland J, Norberg M, Hine D, McCambridge J. Effectiveness of a self-guided web-based cannabis treatment program: Randomized controlled trial. J Med Internet Res 2013;15:e26. http://dx.doi.org/10.2196/jmir.2256
71. Humeniuk R, Ali R, Babor T, Souza-Formigoni ML, de Lacerda RB, Ling W, et al. A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction 2012;107:957–66. http://dx.doi.org/10.1111/j.1360-0443.2011.03740.x
72. Litt MD, Kadden RM, Stephens RS, Marijuana Treatment Project Research Group. Coping and self-efficacy in marijuana treatment: Results from the marijuana treatment project. J Consult Clin Psychol 2005;73:1015–25. http://dx.doi.org/10.1037/0022-006X.73.6.1015
73. ClinicalTrials.Gov. Development and Efficacy Test of Computerized Treatment for Marijuana Dependence. 2013. URL: https://clinicaltrials.gov/show/NCT00594659 (accessed 6 February 2014).
74. Moore BA, Budney AJ. Relapse in outpatient treatment for marijuana dependence. J Subst Abuse Treat 2003;25:85–9. http://dx.doi.org/10.1016/S0740-5472(03)00083-7
75. Fischer B, Jones W, Shuper P, Rehm J. 12-month follow-up of an exploratory ‘brief intervention’ for high-frequency cannabis users among Canadian university students. Subst Abuse Treat Prev Policy 2012;7:15. http://dx.doi.org/10.1186/1747-597X-7-15
76. Hoch E, Noack R, Henker J, Rohrbacher H, Pixa A, Buhringer G, et al. Tailoring CBT to problem profiles of patients with cannabis use disorders. Sucht 2008;54:306.
77. Litt MD, Kadden RM, Kabela-Cormier E, Petry NM. Coping skills training and contingency management treatments for marijuana dependence: Exploring mechanisms of behavior change. Addiction 2008;103:638–48. http://dx.doi.org/10.1111/j.1360-0443.2008.02137.x
78. Lozano BE, Stephens RS, Roffman RA. Abstinence and moderate use goals in the treatment of marijuana dependence. Addiction 2006;101:1589–97. http://dx.doi.org/10.1111/j.1360-0443.2006.01609.x
79. DeMarce JM, Stephens RS, Roffman RA. Psychological distress and marijuana use before and after treatment: Testing cognitive–behavioral matching hypotheses. Addict Behav 2005;30:1055–9. http://dx.doi.org/10.1016/j.addbeh.2004.09.009
80. Hjorthoj C, Fohlmann A, Mette LA, Gluud C, Arendt M, Nordentoft M. CapOpus-intervention study for cannabis use disorder in psychosis. Early Interv Psychiatry 2012;6:28.
81. Budney AJ, Fearer S, Walker DD, Stanger C, Thostenson J, Grabinski M, et al. An initial trial of a computerized behavioral intervention for cannabis use disorder. Drug Alcohol Depend 2011;115:74–9. http://dx.doi.org/10.1016/j.drugalcdep.2010.10.014
82. Kay-Lambkin FJ, Baker AL, Kelly BJ, Lewin TJ. It’s worth a try: The treatment experiences of rural and Urban participants in a randomized controlled trial of computerized psychological treatment for comorbid depression and alcohol/other drug use. J Dual Diagn 2012;8:262–76. http://dx.doi.org/10.1080/15504263.2012.723315
83. Gaudiano BA, Weinstock LM, Miller IW. Improving treatment adherence in patients with bipolar disorder and substance abuse: Rationale and initial development of a novel psychosocial approach. J Psychiatr Pract 2011;17:5–20. http://dx.doi.org/10.1097/01.pra.0000393840.18099.d6
84. Hides LM, Elkins KS, Scaffidi A, Cotton SM, Carroll S, Lubman DI, et al. Does the addition of integrated cognitive behaviour therapy and motivational interviewing improve the outcomes of standard care for young people with comorbid depression and substance misuse? Med J Aust 2011;195:S31–7.
85. Lykke J, Oestrich I, Austin SF, Hesse M. The implementation and evaluation of cognitive milieu therapy for dual diagnosis inpatients: A pragmatic clinical trial. J Dual Diagn 2010;6:58–72. http://dx.doi.org/10.1080/15504260903498763
86. McLellan AT. A randomized controlled trial of brief cognitive–behavioral interventions for cannabis use disorder. J Subst Abuse Treat 2001;21:65–6. http://dx.doi.org/10.1016/S0740-5472(01)00196-9
87. Miller WR. It all depends. Addiction 2008;103:1819–20. http://dx.doi.org/10.1111/j.1360-0443.2008.02359.x
88. Naar-King S. Motivational interviewing in adolescent treatment. Can J Psychiatry 2011;56:651–7.
89. Nery FG, Soares JC. Comorbid bipolar disorder and substance abuse: Evidence-based options. Curr Psychiatry 2011;10:57–66.
90. Pokhrel P, Sussman S, Rohrbach LA, Sun P. Prospective associations of social self-control with drug use among youth from regular and alternative high schools. Subst Abuse Treat Prev Policy 2007;2:22. http://dx.doi.org/10.1186/1747-597X-2-22
91. Riley KJ, Rieckmann T, McCarty D. Implementation of MET/CBT 5 for adolescents. J Behav Health Serv Res 2008;35:304–14. http://dx.doi.org/10.1007/s11414-008-9111-9
92. Hill KP, Toto LH, Lukas SE, Weiss RD, Trksak GH, Rodolico JM, et al. Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: A pilot study. Am J Addict 2013;22:233–8. http://dx.doi.org/10.1111/j.1521-0391.2012.12007.x
93. Englund A, Morrison PD, Nottage J, Hague D, Kane F, Bonaccorso S, et al. Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. J Psychopharmacol 2013;27:19–27. http://dx.doi.org/10.1177/0269881112460109
94. Morgan CJ, Schafer G, Freeman TP, Curran HV. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: Naturalistic study: Naturalistic study. Br J Psychiatry 2010;197:285–90. http://dx.doi.org/10.1192/bjp.bp.110.077503
95. Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer C, et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry 2012;2:e94. http://dx.doi.org/10.1038/tp.2012.15
96. Chagas MH, Eckeli AL, Zuardi AW, Pena-Pereira MA, Sobreira-Neto MA, Sobreira ET, et al. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: A case series. J Clin Pharm Ther 2014;39:564–6. http://dx.doi.org/10.1111/jcpt.12179
97. PRISMA. The PRISMA Statement. URL: www.prisma-statement.org (accessed 29 November 2013).